The call for abstracts closed on the 26 July 2023.
The call for late breakers closed on the 15 September 2023.
Abstract decisions was communicated to authors early October 2023.
HepHIV abstracts should contain original material from recent work that is not yet in publication.
Abstract submissions from multiple research domains: clinical and community research, behavioral science, implementation science, operational research and public policy under the following themes in relation to testing and linkage to care and integrated testing for hepatitis/HIV/STI/TB.
Health & implementation science
- Integrated testing programs for hepatitis/HIV/STI/TB
- Surveillance, monitoring and evaluation (M&E) related to integrated testing
- Access to diagnostics and linkage to care
- Combination prevention for hepatitis/HIV/STI/TB (in the COVID/post-COVID era)
- Post-exposure and pre-exposure prophylaxis (integration with combination prevention and opportunities for testing)
- Information-communication Technologies (ICT) (e-health, M-health) used in relation to testing
- New testing and re-testing strategies
- Self-testing and self-sampling strategies
Society & Social-behavioral science
- Intersecting stigmas and discrimination affecting HIV and Hepatitis Testing
- Test seeking behavioral determinants
- Monitoring the impact of stigma on testing update and linkage to care
- Stakeholder engagement – community and civil society engagement in testing
- Migrants/mobile populations – models of testing and linkage to care
- Engagement and re-engagement of LTFU – developing innovative testing programs
- Novel and integrated approaches to testing for hepatitis/HIV/STI/TB
- Testing in health care settings specific to key populations
- Indicator condition guided testing
- Point-of-care diagnostics in clinical setting
- Knowledge translation to policy and programming
- Political and structural drivers and responses in addressing multiple vulnerabilities – testing and linkage to care
- Political engagement to enhance HIV testing
- Roles of different actors and organizational aspects of testing programs